Literature DB >> 20061363

Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.

Takashi Kohno1, Hideo Kunitoh, Yoko Shimada, Kouya Shiraishi, Yuko Ishii, Koichi Goto, Yuichiro Ohe, Yutaka Nishiwaki, Aya Kuchiba, Seiichiro Yamamoto, Hiroshi Hirose, Akira Oka, Noriko Yanagitani, Ryusei Saito, Hidetoshi Inoko, Jun Yokota.   

Abstract

Adenocarcinoma (ADC) is the commonest histological type of lung cancer, and its weak association with smoking indicates the necessity to identify high-risk individuals for targeted screening and/or prevention. By a genome-wide association study (GWAS), we identified an association of polymorphisms in the 6p21.31 locus containing four human leukocyte antigen (HLA) class II genes with lung ADC risk. DQA1*03 of the HLA-DQA1 gene was defined as a risk allele with odds ratio (OR) of 1.36 [95% confidence interval (CI) = 1.21-1.54, P = 5.3 x 10(-7)] by analysis of 1656 ADC cases and 1173 controls. DQA1*03 and the minor allele for a polymorphism, rs2736100, in TERT, another lung cancer susceptibility locus identified in recent GWASs on Europeans and Americans, were indicated to independently contribute to ADC risk with per allele OR of 1.43 (95% CI = 1.31-1.56, P = 7.8 x 10(-16)). Individuals homozygous both for the DQA1*03 and minor TERT alleles were defined as high-risk individuals with an OR of 4.76 (95% CI = 2.53-9.47, P = 4.2 x 10(-7)). The present results indicated that individuals susceptible to lung ADC can be defined by combined genotypes of HLA-DQA1 and TERT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20061363     DOI: 10.1093/carcin/bgq003

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  28 in total

1.  TERT rs2736100 polymorphism contributes to lung cancer risk: a meta-analysis including 49,869 cases and 73,464 controls.

Authors:  Wei Nie; Yuansheng Zang; Jiquan Chen; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-02-18

2.  Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer: a case-control study in northeast Chinese male population.

Authors:  Yue Zhang; Mengmeng Zhao; Li Shen; Yangwu Ren; Lingyan Su; Xuelian Li; Zhihua Yin; Baosen Zhou
Journal:  Med Oncol       Date:  2014-05-27       Impact factor: 3.064

Review 3.  Genetics of leukocyte telomere length and its role in atherosclerosis.

Authors:  Abraham Aviv
Journal:  Mutat Res       Date:  2011-05-08       Impact factor: 2.433

4.  CLPTM1L polymorphism as a protective factor for lung cancer: a case-control study in southern Chinese population.

Authors:  Tianbo Jin; Bin Li; Na He; Yao Zhang; Ridong Xia; Longli Kang; Yipeng Ding; Dongya Yuan
Journal:  Tumour Biol       Date:  2016-02-06

5.  An analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPs.

Authors:  Hongping Yu; Hui Zhao; Li-E Wang; Younghun Han; Wei V Chen; Christopher I Amos; Thorunn Rafnar; Patrick Sulem; Kari Stefansson; Maria Teresa Landi; Neil Caporaso; Demetrius Albanes; Michael Thun; James D McKay; Paul Brennan; Yufei Wang; Richard S Houlston; Margaret R Spitz; Qingyi Wei
Journal:  DNA Repair (Amst)       Date:  2011-02-05

6.  A functional variant of tandem repeats in human telomerase gene was associated with survival of patients with early stages of non-small cell lung cancer.

Authors:  Luo Wang; Li-E Wang; Li Mao; Margaret R Spitz; Qingyi Wei
Journal:  Clin Cancer Res       Date:  2010-05-13       Impact factor: 12.531

Review 7.  The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.

Authors:  Peng Zou; Aihua Gu; Guixiang Ji; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  BMC Cancer       Date:  2012-01-05       Impact factor: 4.430

8.  Two HLA Class II Gene Variants Are Independently Associated with Pediatric Osteosarcoma Risk.

Authors:  Chenan Zhang; Joseph L Wiemels; Helen M Hansen; Julio Gonzalez-Maya; Alyson A Endicott; Adam J de Smith; Ivan V Smirnov; John S Witte; Libby M Morimoto; Catherine Metayer; Kyle M Walsh
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-07-23       Impact factor: 4.254

9.  Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

Authors:  Bríd M Ryan; Ana I Robles; Andrew C McClary; Majda Haznadar; Elise D Bowman; Sharon R Pine; Derek Brown; Mohammed Khan; Kouya Shiraishi; Takashi Kohno; Hirokazu Okayama; Ramakrishna Modali; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

10.  DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.

Authors:  Jennifer A Doherty; Lori C Sakoda; Melissa M Loomis; Matt J Barnett; Liberto Julianto; Mark D Thornquist; Marian L Neuhouser; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.